Item Type: | Article |
---|---|
Title: | Myeloid cells contribute indirectly to VEGF expression upon hypoxia via activation of Müller cells |
Creators Name: | Nuernberg, C., Kociok, N., Brockmann, C., Lischke, T., Crespo-Garcia, S., Reichhart, N., Wolf, S., Baumgrass, R., Eming, S.A., Beer-Hammer, S. and Joussen, A.M. |
Abstract: | Anti-VEGF-directed therapies have been a milestone for treating retinal vascular diseases. Depletion of monocyte lineage cells suppresses pathological neovascularization in the oxygen-induced retinopathy mouse model. However, the question whether myeloid-derived VEGF-A expression is responsible for the pathogenesis in oxygen-induced retinopathy remained unknown. We analyzed LysMCre-driven myeloid cell-specific VEGF-A knockout mice as well as mice with complete depletion of circulating macrophages through clodronate-liposome treatment in the oxygen-induced retinopathy model by immunohistochemistry, qPCR, and flow cytometry. Furthermore, we analyzed VEGF-A mRNA expression in MIO-M1 cells alone and in co-culture with BV-2 cells in vitro. The myeloid cell-specific VEGF-A knockout did not change relative retinal VEGF-A mRNA levels, the relative avascular area or macrophage/granulocyte numbers in oxygen-induced retinopathy and under normoxic conditions. We observed an insignificantly attenuated pathology in systemically clodronate-liposome treated knockouts but evident VEGF-A expression in activated Müller cells on immunohistochemically stained sections. MIO-M1 cells had significantly higher expression levels of VEGF-A in co-culture with BV-2 cells compared to cultivating MIO-M1 cells alone. Our data show that myeloid-derived cells contribute to pathological neovascularization in oxygen-induced retinopathy through activation of VEGF-A expression in Müller cells. |
Keywords: | VEGF, Oxygen Induced Retinopathy, Myeloid Derived Cells, Macrophages, Microglia Cells, Animals, Mice |
Source: | Experimental Eye Research |
ISSN: | 0014-4835 |
Publisher: | Elsevier / Academic Press |
Volume: | 166 |
Page Range: | 56-69 |
Date: | January 2018 |
Official Publication: | https://doi.org/10.1016/j.exer.2017.10.011 |
PubMed: | View item in PubMed |
Repository Staff Only: item control page